Back

Conclusion.

29 June 2021 (18:29 - 18:30)
Organised by:
Congress Presentation Part of: Unleashing the full potential of SGLT2 inhibition in heart failure: optimizing patient benefit in clinical practice Heart Failure Open Access Heart Failure 2021

About the speaker

Photo
Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor I. Pina (Philadelphia, US)
Video
Presentation thumbnail
Optimizing treatment initiation: time matters.
Professor J. Butler (Dallas, US) Professor M. Packer (Dallas, US)
Video
Presentation thumbnail
Optimizing SGLT2 inhibition: recent data.
Professor S. Anker (Berlin, DE) Professor A. Stewart Coats (Sydney, AU)
Video
Presentation thumbnail
Live Q&A.
Video

Access the full session

Session thumbnail
Unleashing the full potential of SGLT2 inhibition in heart failure: optimizing patient benefit in clinical practice
Video

The Event

Event poster

Heart Failure 2021

29 June 2021 18:29 CET
You may be interested in
thumbnail
Congress Presentation
Risk of all-cause mortality and heart failure hospitalizations in patients treated with vericiguat in real world settings
17 May 2025
thumbnail
Congress Presentation
Ablation STrategies for Repeat PrOcedures in Patients with Atrial Fibrillation Recurrences despite Durable Pulmonary Vein Isolation
8 April 2024
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice
26 August 2023
thumbnail
Congress Presentation
When to stop? Real-world decision pathways for transthyretin stabilizer discontinuation in cardiac amyloidosis
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources